is engaged in the development of medical diagnostic tools: its allergy testing device and its chiropractic outcome-measuring instrument.
Krucker, President and CEO of ELAST Technologies, Inc.
ELAST Technologies also continues its work to perfect its allergy testing device, the Electronic Allergo Sensitivity Test or the ELAST Device(TM).
Krucker also emphasized ELAST
Technologies' continued commitment to the perfection of its allergy testing device, the Electronic Allergo Sensitivity Test or the ELAST
In an effort to meet that projection ELAST
established a chiropractic division in August 2000 dedicated to marketing the Bio-Potential Instrument to the chiropractic community.
is engaged in the development of two separate diagnostic tools: its allergy testing device and its chiropractic outcome-measuring instrument.
Device(TM) is a patented, non-invasive diagnostic tool designed to accurately diagnose allergies, as well as food and chemical sensitivities immediately and without any of the pain or expense associated with currently employed testing methods.
ELAST Technologies is currently engaged in negotiations with two other international firms both desirous of obtaining the exclusive distribution rights for ELAST Technologies' patented allergy testing device in Japan and Mexico respectively, and has already finalized an agreement for exclusive distribution rights in Australia and New Zealand.
The ELAST Device(TM) has universal application and the agreements assure its marketing and distribution immediately upon its final development and prior to United States FDA approval.